| Website | glycominds.com |
| Category | BioTech |
| Phone | 972-8-9181080 |
| Employees |
| TOTAL | $1M |
| VENTURE FUNDING TOTAL | $1M |
| Venture Round, 1/05 BRM Capital Millennium II Materials Technology Fund | $1M |
Glycominds, a molecular diagnostics company, develops and commercializes autoimmune and chronic inflammatory disease management tools and services with a distinctive focus on the Multiple Sclerosis market. Their proprietary tests allow physicians to help identify patients at a higher risk for more severe disease outcomes.
